Bank of Montreal
NEOS

Bank of Montreal’s Neos Therapeutics, Inc NEOS Stock Holding History

Bank of Montreal’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-115
Closed – – 5102
2019
Q2 		$0 Buy
115
+109
+1,817% +$201 ﹤0.01% 5170
2019
Q1 		$0 Sell
6
-655
-99% -$1.54K ﹤0.01% 4955
2018
Q4 		$1K Sell
661
-335
-34% -$940 ﹤0.01% 4603
2018
Q3 		$4K Sell
996
-5
-0.5% -$28 ﹤0.01% 4195
2018
Q2 		$6K Buy
1,001
+501
+100% +$3.73K ﹤0.01% 4107
2018
Q1 		$4K Buy
+500
New +$4.77K ﹤0.01% 3968
2017
Q4 		– Sell
-8
Closed – – 4405
2017
Q3 		$0 Buy
8
+6
+300% +$46 ﹤0.01% 4382
2017
Q2 		$0 Sell
2
-7,998
-100% -$60.4K ﹤0.01% 4349
2017
Q1 		$58K Buy
8,000
+7,976
+33,233% +$49.5K ﹤0.01% 3029
2016
Q4 		$0 Sell
24
-22
-48% -$149 ﹤0.01% 4255
2016
Q3 		$0 Buy
46
+26
+130% +$206 ﹤0.01% 4263
2016
Q2 		$0 Buy
20
+13
+186% +$124 ﹤0.01% 4413
2016
Q1 		$0 Buy
+7
New +$74 ﹤0.01% 4474
2015
Q4 		– Sell
-28
Closed -$1K – 4508
2015
Q3 		$1K Buy
+28
New +$617 ﹤0.01% 3914

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of Montreal's NEOS Position: Q3 2019 in Review

Bank of Montreal sold out of Neos Therapeutics, Inc (NEOS) in Q3 2019, closing a stake of 115 shares.

Bank of Montreal first reported a position in NEOS in Q3 2015 and held it in 14 quarters. The position peaked at $58K in Q1 2017. 51 funds tracked by Wall St. Rank hold NEOS as of Q3 2019.

  • Bank of Montreal reported no remaining Neos Therapeutics, Inc position as of Q3 2019 after selling out during the quarter.
  • Bank of Montreal sold 115 Neos Therapeutics, Inc shares in Q3 2019.
  • Bank of Montreal first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 14 quarters.
  • Bank of Montreal's Neos Therapeutics, Inc position peaked at $58K in Q1 2017.
  • 51 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q3 2019.

Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.